 Patrick Hume
Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cigarette Smoking | 2 | 2022 | 85 | 1.450 |
Why?
| | Lung | 7 | 2023 | 3664 | 0.860 |
Why?
| | Perfusion | 1 | 2021 | 153 | 0.750 |
Why?
| | Pressure | 1 | 2021 | 226 | 0.730 |
Why?
| | Blood Vessels | 1 | 2021 | 187 | 0.690 |
Why?
| | Pulmonary Emphysema | 1 | 2022 | 327 | 0.670 |
Why?
| | Polyethylene Glycols | 3 | 2012 | 578 | 0.640 |
Why?
| | Pulmonary Alveoli | 1 | 2021 | 384 | 0.640 |
Why?
| | Macrophages, Alveolar | 2 | 2022 | 359 | 0.630 |
Why?
| | Patient Care Planning | 1 | 2018 | 143 | 0.610 |
Why?
| | Hydrogels | 4 | 2023 | 582 | 0.590 |
Why?
| | Shock, Septic | 1 | 2018 | 187 | 0.570 |
Why?
| | Hospital Mortality | 1 | 2018 | 814 | 0.480 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 1137 | 0.470 |
Why?
| | Metalloporphyrins | 1 | 2011 | 103 | 0.390 |
Why?
| | Coated Materials, Biocompatible | 1 | 2011 | 58 | 0.390 |
Why?
| | Superoxides | 1 | 2011 | 221 | 0.380 |
Why?
| | Biomimetic Materials | 1 | 2011 | 66 | 0.380 |
Why?
| | fas Receptor | 1 | 2010 | 98 | 0.360 |
Why?
| | Photochemistry | 1 | 2010 | 136 | 0.350 |
Why?
| | Superoxide Dismutase | 1 | 2011 | 339 | 0.350 |
Why?
| | Polymers | 2 | 2011 | 482 | 0.350 |
Why?
| | Dendritic Cells | 1 | 2012 | 442 | 0.330 |
Why?
| | T-Lymphocytes | 3 | 2012 | 1774 | 0.330 |
Why?
| | Mice | 10 | 2023 | 15520 | 0.320 |
Why?
| | Biocompatible Materials | 1 | 2012 | 378 | 0.320 |
Why?
| | Leukocytes | 2 | 2022 | 290 | 0.240 |
Why?
| | Apoptosis | 2 | 2011 | 2484 | 0.240 |
Why?
| | Animals | 10 | 2023 | 33381 | 0.220 |
Why?
| | X-Ray Microtomography | 1 | 2022 | 79 | 0.210 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2022 | 33 | 0.210 |
Why?
| | Vascular System Injuries | 1 | 2023 | 70 | 0.210 |
Why?
| | Vaping | 1 | 2023 | 51 | 0.210 |
Why?
| | Precancerous Conditions | 1 | 2023 | 160 | 0.210 |
Why?
| | Neuropeptides | 1 | 2022 | 68 | 0.210 |
Why?
| | Ventilator-Induced Lung Injury | 1 | 2022 | 49 | 0.200 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2023 | 81 | 0.200 |
Why?
| | Fixatives | 1 | 2021 | 16 | 0.200 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 246 | 0.190 |
Why?
| | Leukosialin | 1 | 2020 | 15 | 0.190 |
Why?
| | Mannose-Binding Lectins | 1 | 2020 | 14 | 0.190 |
Why?
| | Optical Devices | 1 | 2020 | 12 | 0.190 |
Why?
| | Lung Injury | 1 | 2023 | 210 | 0.190 |
Why?
| | Killer Cells, Natural | 1 | 2023 | 381 | 0.190 |
Why?
| | Lectins, C-Type | 1 | 2020 | 63 | 0.190 |
Why?
| | Medical Writing | 1 | 2019 | 2 | 0.180 |
Why?
| | Cell Count | 1 | 2020 | 315 | 0.180 |
Why?
| | Boston | 1 | 2018 | 76 | 0.160 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 702 | 0.160 |
Why?
| | Receptors, Cell Surface | 1 | 2020 | 367 | 0.160 |
Why?
| | Tissue Donors | 1 | 2020 | 336 | 0.160 |
Why?
| | Mice, Transgenic | 1 | 2022 | 2025 | 0.150 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 250 | 0.140 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1691 | 0.140 |
Why?
| | Linear Models | 1 | 2018 | 827 | 0.130 |
Why?
| | Macrophages | 1 | 2022 | 1324 | 0.130 |
Why?
| | Humans | 12 | 2023 | 118974 | 0.120 |
Why?
| | Disease Management | 1 | 2018 | 571 | 0.120 |
Why?
| | Flow Cytometry | 2 | 2022 | 1085 | 0.120 |
Why?
| | Biomedical Research | 1 | 2019 | 612 | 0.120 |
Why?
| | Research Design | 1 | 2019 | 969 | 0.120 |
Why?
| | Mice, Inbred C57BL | 1 | 2022 | 4908 | 0.110 |
Why?
| | Case-Control Studies | 1 | 2020 | 3171 | 0.110 |
Why?
| | Disease Models, Animal | 1 | 2022 | 3730 | 0.110 |
Why?
| | Glucose Oxidase | 1 | 2011 | 20 | 0.100 |
Why?
| | Coculture Techniques | 1 | 2012 | 208 | 0.100 |
Why?
| | 3T3 Cells | 1 | 2011 | 141 | 0.100 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2012 | 164 | 0.100 |
Why?
| | Lung Neoplasms | 1 | 2023 | 2220 | 0.100 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 574 | 0.090 |
Why?
| | Materials Testing | 1 | 2012 | 359 | 0.090 |
Why?
| | Jurkat Cells | 1 | 2010 | 134 | 0.090 |
Why?
| | Interleukin-10 | 1 | 2012 | 306 | 0.090 |
Why?
| | Middle Aged | 2 | 2020 | 27617 | 0.080 |
Why?
| | Cell Adhesion | 1 | 2010 | 443 | 0.080 |
Why?
| | Lymphocyte Activation | 1 | 2012 | 1067 | 0.080 |
Why?
| | Immunosuppressive Agents | 1 | 2012 | 681 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 827 | 0.080 |
Why?
| | Genetic Enhancement | 1 | 2006 | 6 | 0.070 |
Why?
| | DNA Probes | 1 | 2006 | 60 | 0.070 |
Why?
| | Cell Line | 1 | 2011 | 2707 | 0.070 |
Why?
| | Protein Engineering | 1 | 2006 | 107 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2012 | 1753 | 0.060 |
Why?
| | Escherichia coli Proteins | 1 | 2006 | 170 | 0.060 |
Why?
| | Urethane | 1 | 2023 | 41 | 0.060 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2006 | 770 | 0.060 |
Why?
| | Male | 2 | 2020 | 57801 | 0.060 |
Why?
| | Cells, Cultured | 1 | 2011 | 4077 | 0.060 |
Why?
| | Immunoglobulins | 1 | 2023 | 154 | 0.060 |
Why?
| | Receptors, KIR | 1 | 2023 | 89 | 0.060 |
Why?
| | Female | 2 | 2020 | 61565 | 0.050 |
Why?
| | Ceramides | 1 | 2023 | 104 | 0.050 |
Why?
| | Thymus Gland | 1 | 2023 | 300 | 0.050 |
Why?
| | Tidal Volume | 1 | 2022 | 74 | 0.050 |
Why?
| | Positive-Pressure Respiration | 1 | 2022 | 70 | 0.050 |
Why?
| | Dronabinol | 1 | 2023 | 121 | 0.050 |
Why?
| | Escherichia coli | 1 | 2006 | 758 | 0.050 |
Why?
| | Aged | 1 | 2020 | 19657 | 0.050 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 310 | 0.050 |
Why?
| | Adolescent | 1 | 2020 | 18480 | 0.050 |
Why?
| | Ligands | 1 | 2023 | 567 | 0.050 |
Why?
| | Time Factors | 1 | 2011 | 6412 | 0.050 |
Why?
| | Financing, Organized | 1 | 2019 | 34 | 0.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2022 | 613 | 0.040 |
Why?
| | Signal Transduction | 1 | 2012 | 4709 | 0.040 |
Why?
| | Adult | 1 | 2020 | 31512 | 0.040 |
Why?
| | Respiration, Artificial | 1 | 2022 | 545 | 0.040 |
Why?
| | Teaching | 1 | 2019 | 236 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2022 | 732 | 0.040 |
Why?
| | Hypoxia | 1 | 2022 | 963 | 0.030 |
Why?
| | United States | 1 | 2023 | 12555 | 0.020 |
Why?
| | Drug Tolerance | 1 | 2006 | 78 | 0.020 |
Why?
| | Heat-Shock Response | 1 | 2006 | 59 | 0.020 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2006 | 363 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2006 | 314 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2006 | 1308 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2006 | 2874 | 0.010 |
Why?
| | Mutation | 1 | 2006 | 3457 | 0.010 |
Why?
|
|
Hume's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|